DexCom, Inc. (LON:0A4M)

Market Cap	19.48B -29.8%
Revenue (ttm)	3.36B +14.2%
Net Income	536.16M +5.9%
EPS	1.34 +7.8%
Shares Out	n/a
PE Ratio	36.33
Forward PE	27.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,824
Average Volume	10,341
Open	73.34
Previous Close	70.89
Day's Range	73.34 - 73.34
52-Week Range	56.00 - 90.77
Beta	n/a
RSI	52.30
Earnings Date	Feb 12, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD